Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (331)

2024

  1. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing

    International Journal of Medical Microbiology, Vol. 314

  2. Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic

    Mycoses, Vol. 67, Núm. 1

  4. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution

    Mycoses, Vol. 67, Núm. 3

  5. Impact of an interventional bundle on complications associated with peripheral venous catheters in elderly patients

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 703-712

  6. Impact of the Mediterranean Diet on the Gut Microbiome of a Well-Defined Cohort of Healthy Individuals

    Nutrients, Vol. 16, Núm. 6

  7. Infectious complications following major heart surgery from the day of the surgery to hospital discharge

    BMC Infectious Diseases, Vol. 24, Núm. 1

  8. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine

  9. Microevolution, reinfection and highly complex genomic diversity in patients with sequential isolates of Mycobacterium abscessus

    Nature Communications, Vol. 15, Núm. 1

  10. Mining genomic repositories to further our knowledge of the extent of SARS-CoV-2 co-infections

    Microbial genomics, Vol. 10, Núm. 1

  11. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

  12. Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2

    Frontiers in Immunology, Vol. 15

  13. No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir

    Journal of Medical Virology

2023

  1. A One Health approach revealed the long-term role of Mycobacterium caprae as the hidden cause of human tuberculosis in a region of Spain, 2003 to 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 12

  2. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  3. Alternative molecular and genomic strategies to provide a rapid response to alerts concerning the introduction of new emerging SARS-CoV-2 variants: the Omicron alert

    Microbiology Spectrum, Vol. 11, Núm. 5

  4. Amphotericin B, itraconazole, posaconazole, and isavuconazole MICs against clinical Mucorales isolates obtained by visual inspection and spectrophotometric reading according to the EUCAST 9.4 procedure

    Medical mycology, Vol. 61, Núm. 5

  5. An In Vitro Study to Assess the Best Strategy for the Chemical Debridement of Periprosthetic Joint Infection

    Antibiotics, Vol. 12, Núm. 10

  6. Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates

    Clinical Microbiology and Infection, Vol. 29, Núm. 12, pp. 1604.e1-1604.e6

  7. Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms

    Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922